Â鶹´«Ã½Ó³»­

Embargo policy for Neurology^® journal studies

Articles appearing in the Â鶹´«Ã½Ó³»­’s medical journal Neurology^®, as well as other Neurology^® journal publications, are embargoed for release to the public until 4:00 p.m. ET on the day of online publication.

If there are any questions concerning an embargo date and time, please contact the Â鶹´«Ã½Ó³»­ Media and Public Relations team at media@aan.com.

Credentialed journalists may request further information about Neurology^® journal articles, including advance copies of articles and help coordinating interviews with researchers, by sending an email to media@aan.com.

View Neurology^® and Â鶹´«Ã½Ó³»­ press releases.

Embargo policies for 2026 Â鶹´«Ã½Ó³»­ Annual Meeting abstracts

The following policies apply to Â鶹´«Ã½Ó³»­ Annual Meeting abstracts, not including late-breaking science abstracts, to be presented at the 2026 Â鶹´«Ã½Ó³»­ Annual Meeting, being held April 18-22 in Chicago.

• Abstracts, not including late-breaking science abstracts, will be posted online at 4:00 p.m. ET, Thursday, March 5, 2026.
• Authors of abstracts featured in an Â鶹´«Ã½Ó³»­ press release must abide by Â鶹´«Ã½Ó³»­ embargo policies.

  • Authors will be notified at acceptance if their abstract has been selected for an Â鶹´«Ã½Ó³»­ press release. Embargo dates for these abstracts will be communicated to the authors.

  • The Â鶹´«Ã½Ó³»­ strictly enforces its embargo policy for abstracts featured in an Â鶹´«Ã½Ó³»­ press release, which prohibits the distribution or publication of the contents of abstracts ahead of the embargo date and time.

  • When the embargo lifts for an abstract featured in an Â鶹´«Ã½Ó³»­ press release, the embargo also lifts on additional research data related to but not included in the abstract. This includes data to be presented at the Â鶹´«Ã½Ó³»­ Annual Meeting in presentations and posters. While additional data beyond the abstract may be included in an external press release after the embargo lifts, posters or slide presentations created for the Â鶹´«Ã½Ó³»­ Annual Meeting must not be shared ahead of their presentation time at the Â鶹´«Ã½Ó³»­ Annual Meeting.

• Embargoed press releases on newsworthy abstracts, not including late-breaking science abstracts, will be distributed to credentialed journalists by late February 2026.

• Authors may present an accepted abstract at a subspecialty meeting ahead of 4:00 p.m. ET, Thursday, March 5, 2026, if the abstract has not been selected for the Â鶹´«Ã½Ó³»­ Annual Meeting press release program and is not a late-breaking science abstract.

Only abstracts featured in an Â鶹´«Ã½Ó³»­ press release and all late-breaking science abstracts are embargoed.

• For abstracts that are not embargoed, additional research data related to but not included in the abstract may be shared in a press release. This includes data to be presented at the Â鶹´«Ã½Ó³»­ Annual Meeting in presentations and posters. While additional data beyond the abstract may be included in an external press release, posters or slide presentations created for the Â鶹´«Ã½Ó³»­ Annual Meeting must not be shared ahead of their presentation time at the Â鶹´«Ã½Ó³»­ Annual Meeting.

The following policies apply to late-breaking science abstracts to be presented at the 2026 Â鶹´«Ã½Ó³»­ Annual Meeting, being held April 18-22 in Chicago.

• The embargoes for late-breaking science abstracts correspond with their presentation times at the Â鶹´«Ã½Ó³»­ Annual Meeting.
  • Late-breaking Science 1: Abstracts presented in this session are embargoed until 4:00 p.m. ET/5:00 p.m. CT, Sunday, April 19, 2026
  • Late-breaking Science 2: Abstracts presented in this session are embargoed until 4:45 p.m. ET/5:45 p.m. CT, Tuesday, April 21, 2026
• Titles of late-breaking abstracts will be made available on Â鶹´«Ã½Ó³»­.com ahead of the meeting.
  • Only abstract titles may be shared publicly before their embargoes lift.
• Late-breaking science abstracts will be posted online when their embargoes lift.
• All authors of all late-breaking science abstracts must abide by Â鶹´«Ã½Ó³»­ embargo policies.
• Authors who must report their findings publicly before the embargo date due to Securities and Exchange Commission (SEC) regulations are asked to notify the Â鶹´«Ã½Ó³»­ by sending an email to media@aan.com.
• When the embargoes lift for late-breaking science abstracts, the embargoes also lift for additional research data related to but not included in the late-breaking science abstracts. This includes data to be presented at the Â鶹´«Ã½Ó³»­ Annual Meeting in presentations and posters.
• Late-breaking science abstracts are accepted from neurologists, neuroscientists, and other researchers whose work is of major scientific importance, warranting expedited presentation and publication. Key aspects of the research must have been conducted after October 14, 2025.

Additional information regarding policies for members of industry can be found in the Â鶹´«Ã½Ó³»­ Annual Meeting Press Room policies for industry.

For questions regarding Â鶹´«Ã½Ó³»­ Annual Meeting policies, please email media@aan.com.

Sanctions for embargo violators

Failure to abide by the Â鶹´«Ã½Ó³»­ embargoes will result in suspension of press credentials, which will affect access privileges to embargoed content for the journal Neurology^®, embargoed press materials, and embargoed abstracts presented at the Â鶹´«Ã½Ó³»­ Annual Meeting.

Press credentials for embargoed material

Journalists must provide the following credentials for review by Â鶹´«Ã½Ó³»­ staff in order to receive embargoed content from the Neurology^® journal and the Â鶹´«Ã½Ó³»­ Annual Meeting press release program.

• Business card or a link to a staff bio page on a publication's website, clearly showing press affiliation (a print, online, or broadcast news organization) and position (editor, writer, producer, reporter, videographer). If a business card is used, an additional form of identification may be requested.
• Letter of assignment on official company letterhead from an editor of a recognized publication or a producer of a broadcast program certifying that you are covering the study or abstract for the respective news organization.
• At least two published bylined samples of editorial and/or news work.
• Published bylined samples of coverage from previous articles about the Neurology^® journal or the Â鶹´«Ã½Ó³»­ Annual Meeting (if applicable).